An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Since the onset of the COVID-19 pandemic, the prevalence of obesity in Canada has increased at a greater rate.

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

New research reveals that people in rich and poor nations burn similar calories daily, pointing to diet as the real cause of ...

CBSE's recent circular highlights the obesity epidemic in India, citing NFHS-5 data. With projections indicating a rise in ...

A sweeping international study finds daily calorie burn is similar across countries — pointing to ultra-processed foods and ...

Three patient outcomes were measured in this new study: time to onset of ocular-related myasthenia gravis, Activities of ...

Hengrui Pharma and Kailera Therapeutics have reported positive topline data from the former’s Phase III trial (HRS9531-301) ...

The CBSE noted that early lifestyle habits are critical, stating that childhood obesity is often rooted in poor dietary ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

The Ohio Department of Administrative Services announced state employees’ Medicaid coverage for GLP-1 obesity management ...